Orion to host Capital Markets Day today, 22 May 2025, in Helsinki

Core Insights - Orion is hosting its Capital Markets Day on May 22, 2025, in Helsinki, focusing on its growth strategy and financial objectives without announcing new targets [1][5] - The company has three biologics assets in late research phases for immuno-oncology, with plans to initiate clinical phase I trials within the next 12 to 24 months [3][7] - Orion's Easyhaler® product portfolio for asthma and COPD is expected to exceed EUR 300 million in peak annual sales, driven by a shift towards dry-powder inhalers due to lower CO2 emissions [4][7] Company Overview - Orion is a Nordic pharmaceutical company with over a hundred years of experience, developing and marketing human and veterinary pharmaceuticals [6] - The company reported net sales of EUR 1,542 million in 2024 and employs approximately 3,700 professionals globally [6]